Copy Testing Surveys

ASPA COVID-19 Public Education Campaign Market Research

Part A - Attachment J_COVID-19 Copy Testing Survey External IRB Determination

Copy Testing Surveys

OMB: 0990-0476

Document [pdf]
Download: pdf | pdf
BRANY SBER IRB
DATE: 01/20/2021
TO:
Kristin Pondel
FROM: Raffaella Hart, MS, CIP, BRANY SBER IRB (IRB00010793)
SUBMISSION TYPE:
SBER-Initial Review (Event ID# 178156)
PROTOCOL NUMBER: 21-001-821
STUDY TITLE:
HHS COVID-19 Public Education Campaign Vaccine Readiness Creative Testing
Survey.
IRB ACTION:

Approved - SBER

APPROVAL DATE:
EXPIRATION DATE:
REVIEW TYPE:

01/20/2021
Non-expiring
Expedited Initial Review

Thank you for your submission for the above-referenced study.
1. BRANY SBER IRB Determination
Your submission was APPROVED by the BRANY SBER IRB via expedited review under categories
6 and 7. This approval requires that all procedures and activities are performed in accordance
with relevant state and local law (including tribal law, when applicable).
2. Submitted Documents
a. 21-001-Pondell_SBER Study Application-2021-01-13.pdf
b. IRB Abstract.docx
c. HHS COVID-19 Public Education Campaign Creative Testing Survey Protocol 1.12.21.docx
d. HHS COVID-19 Public Education Campaign Draft Creative Testing Questionnaire 18 JAN
2021_clean.docx
e. Informed Consent Form_Quant_IRB edits_clean.docx
f. Email Invitation.docx
Modifications are in accord with those required by the IRB, and were incorporated as indicated in
the redlined versions contained within the IRBManager record.
3. Provisions of BRANY SBER IRB Approval
a. This study requires consent of subjects to be obtained. You must continue to monitor
the subject’s willingness to be in the study for the duration of the subject’s
participation. Only use the current IRB-approved and stamped forms in the consent
process. When documented consent is required, each subject must receive a copy of
his/her signed consent/permission/assent document, and consent forms signed by
subjects in this study must be kept by the Principal Investigator for at least 3 years, or
longer if required by your institution.
b. All research must be conducted in accordance with this approved submission. Any
changes to the approved study must be reviewed and approved by the BRANY SBER IRB
BRANY | 1981 Marcus Avenue, Suite 210, Lake Success, NY 11042 | 516.470.6900 T | 516-470-6903 F | www.brany.com
Page 1 of 2

BRANY SBER IRB
prior to implementation, except when necessary to eliminate an apparent immediate
hazard to the subject.
c. Unanticipated problems (including serious adverse events, if applicable) must be
reported to BRANY SBER IRB within 5 days of discovery using Form IRB-4 (Reporting
Form for Events that Require Prompt Reporting to the IRB).
d. Any complaints or issues of non-compliance must be immediately reported to BRANY
SBER IRB.
4. Consent – Waiver of Documentation
BRANY SBER IRB determined that your request for waiver of documentation of informed
consent satisfies the criteria set forth in 45 CFR 46.117(c)(3).
5. Study Personnel
The following study personnel have been approved to participate in this research project.
a. Kristin Pondel
b. Stephanie Miles
c. Lauren Angel
d. Leah Hoffman
e. Lindsey Strausser
6. Non-Expiring IRB Approval Period:
This study was reviewed under the Revised Common Rule (2018 requirements) and therefore
does not require continuing review in accordance with 45 CFR 46.109(f)(1)(i).
However, BRANY SBER IRB requires you "check in" at least annually to ensure your study status
is up to date and in compliance. Your Annual Report to BRANY IRB is due on 01/20/2022. If
your research is completed before then, you must submit a notification of study closure to
BRANY SBER IRB (use the xForm called: SBER-Study Status Change (Closed/Enrollment Closed)).
If you have any questions or require any additional information, please call me at 516-470-6909 or send
an email to me at rhart@brany.com. Thank you.

BRANY | 1981 Marcus Avenue, Suite 210, Lake Success, NY 11042 | 516.470.6900 T | 516-470-6903 F | www.brany.com
Page 2 of 2


File Typeapplication/pdf
AuthorKimberly Irvine
File Modified2021-01-20
File Created2021-01-20

© 2024 OMB.report | Privacy Policy